Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

In this article we are going to estimate the intrinsic value of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by taking the expected future cash flows and discounting them to their present value.

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Gemini 2.0 Flash is the base model that powers the free version of Gemini. It replaces Gemini 1.5 Flash which was released ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Google has made Gemini 2.0 "generally available" through the Gemini API in Google AI Studio and Vertex AI, marking a ...

The Gemini 2.0 Flash model is also now generally available through the Gemini API in Google AI Studio and Vertex AI. This ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Google DeepMind has made available Gemini 2.0 Flash and introduced new models, including Gemini 2.0 Pro Experimental and ...

Google's Gemini 2.0 just rolled out to everyone. The tech giant has several models that compete with trending tech from ...